Proactive - Interviews for investors

Proactive’s Tylah Tully breaks down ‘Just the Facts’ of the latest news from Triangle Energy (Global) Ltd (ASX:TEG).

The company has awarded a rig contract to Silver City Drilling for the Becos-1 well in the Perth Basin, where it holds a 50% interest, alongside partners Strike Energy and Echelon Resources. Drilling operations for this exploration well are planned to commence in late March 2025. The Silver City Rig 24 will mobilise from the Canning Basin to conduct workovers in the Perth Basin prior to beginning the Becos-1 campaign. These workovers are scheduled on a 12-hour basis and will include a break over the Christmas period.

Becos-1 is expected to explore resources ranging from 1 to 21 million barrels, with a best estimate of 5 million barrels and a 20% chance of geological success. The primary drilling targets are the Arranoo and Bookara sandstones, located at depths between 700 and 800 metres, with an additional opportunity to reach the Kingia sandstone. The entire operation is projected to span 12 days, with seven days allocated for drilling.

Triangle says that the rig contract signifies substantial progress towards the planned drilling, bolstered by full funding from a recent payment under the Cliff Head agreement.

#ProactiveInvestors #TriangleEnergy #ASX #JusttheFacts #PerthBasin #Becos1 #OilExploration #EnergyDevelopment #DrillingCampaign #OilAndGas #AustraliaEnergy #StrikeEnergy #EchelonResources #ResourceExploration #EnergyInvestment #OilProduction #NaturalResources #EnergyProjects #SilverCityDrilling #OilIndustry #EnergyNews #ExplorationUpdate #ConventionalOil

Piche Resources Ltd (ASX: PR2) executive chairman John (Gus) Simpson talks with Proactive’s Tylah Tully about the company’s latest updates, its major projects and what sets it apart for investors.

Simpson provided insights on three of Piche’s prominent projects: the Ashburton Uranium Project in Australia, Sierra Cuadrata Uranium Project in Argentina, and Cerro Chacon Gold Project in Argentina.

In Australia, Ashburton has delivered promising results, with recent drilling data reflecting its potential.

Discussing Argentina, Simpson shared ongoing efforts at Sierra Cuadrata, highlighting the project’s potential in the uranium sector.

Furthermore, he provided an update on Cerro Chacon, Piche’s gold project, emphasizing the company’s strategy and achievements in developing valuable assets across diverse geographies.

These initiatives form the foundation of Piche’s investor appeal. With a portfolio focused on high-demand resources, the company is positioning itself to leverage the global demand for uranium and gold.

As Simpson noted, “We’re in elephant country, with all of these projects having the potential to be world-class assets in two of the most significant commodities currently in the world.”

#ProactiveInvestors #PicheResources #ASX #MiningProjects #AshburtonProject #UraniumMining #GoldMining #ArgentinaMining #InvestorUpdates #MiningIndustry #ProactiveInvestors #NaturalResources

Imugene Ltd (ASX:IMU) managing director and CEO Leslie Chong joins Proactive’s Tylah Tully to discuss the company’s latest update. A bile tract cancer patient in its Phase 1 MAST (Metastatic Advanced Solid Tumours) trial has maintained a complete response (CR) for over two years.

The MAST study is assessing the safety and efficacy of Imugene’s oncolytic virotherapy, CF33-hNIS (VAXINIA), designed to target and destroy cancer cells.

The bile tract cancer expansion of the trial recently also cleared its first patient cohort, with no dose-limiting toxicities observed, and enrolment is now open for up to 10 additional patients.

VAXINIA has received both FDA Fast Track Designation (November 2023) and Orphan Drug Designation (September 2024) for treating bile tract cancer, supporting faster regulatory pathways and potential incentives such as market exclusivity upon approval.

Additionally, Imugene's intellectual property around CF33 received a US patent extension to 2040, covering both VAXINIA and CHECKVacc variants, reinforcing its presence in the US oncology market.

Chong highlighted the patient’s prolonged response and the importance of the recent patent extension in strengthening Imugene’s position in the core healthcare market.

The company continues to recruit patients for the bile tract cancer segment of the trial.

#ProactiveInvetstors #Imugene #ASX #CancerResearch #Oncology #BileTractCancer #MASTTrial #VAXINIA #CF33Virus #ClinicalTrial #FDAFastTrack #OrphanDrugDesignation #PatentExtension #CancerTreatment #OncolyticVirus #Immunotherapy #MedicalBreakthrough #CancerSurvivorship #USHealthcare #DrugDevelopment #CancerInnovation #Biotechnology

Proactive’s Tylah Tully breaks down ‘Just the Facts’ of the latest news from FireFly Metals Ltd (ASX: FFM).

The company has entered into a binding agreement to acquire the Tilt Cove copper-gold exploration project in Newfoundland, Canada, from Signal Gold Inc. for C$3.07 million.

The payment comprises C$2.5 million in FireFly shares and C$570,000 in cash, with an additional C$1 million contingent on defining a minimum 500,000-ounce gold equivalent resource at 1 g/t.

This acquisition expands FireFly’s Green Bay Copper-Gold Project area by 115 square kilometres, increasing its total exploration area by 54% to approximately 326 square kilometres.

Historically, Tilt Cove produced around 170,000 tonnes of copper and 50,000 ounces of gold from the late 19th century through intermittent operations ending in 1967.

The region is considered highly prospective for volcanogenic massive sulphide (VMS) deposits, similar to those at FireFly's nearby Ming mine, which has a resource of 59 million tonnes at 2% copper equivalent.

With A$88 million in cash as of October 2024, FireFly is well-funded to support the acquisition and its ongoing exploration objectives, aligning with its strategy to build shareholder value through targeted resource expansion.

#ProactiveInvestors #FireFlyMetals #ASX #JusttheFacts #CopperGold #MiningAcquisition #TiltCoveProject #GreenBayProject #ResourceExpansion #VMSDeposits #HistoricMining #MineralExploration #NewfoundlandMining #MiningInvestment #GeologicalExploration #GoldMining #CopperMining #MiningNews #HighGradeMinerals #SignalGold #ShareholderValue #ASX #MiningProjects

Clean Power Hydrogen CEO Jonathan Duffy joined Steve Darling from Proactive to share news about the company’s new license agreement with Lisheen H2 Energy Park Limited, known as Hidrigin. The collaboration includes a License Agreement granting Hidrigin the rights to manufacture up to 2GW of CPH2’s innovative MFE electrolyser technology over the next 20 years. Additionally, the agreement encompasses a Sales Contract for the immediate delivery of a 1MW MFE220 electrolyser unit by CPH2, marking a significant advancement in Ireland's hydrogen infrastructure.

Under the License Agreement, the electrolysers built will be dedicated exclusively to Hidrigin and will not be sold to third parties. CPH2 will receive staged payments as project milestones are achieved, as well as revenue from component sales and a per-unit technology fee. Hidrigin plans to integrate these electrolysers into its solar and wind energy projects, producing green hydrogen for commercial sale via its Lisheen BioEnergy Campus.

Backed by €100 million in funding, Hidrigin’s first green hydrogen pilot project is expected to start in 2025, with the first Irish-made MFE220 unit anticipated for completion the same year. This agreement aligns with CPH2’s mission to expand clean hydrogen production and bolster Ireland’s renewable energy infrastructure, fostering growth in the hydrogen economy and supporting nationwide decarbonization goals.

#proactiveinvestors #cph2 #cleanpowerhydrogen #aim #cph2 #invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews

Delivra Health Brands CEO Gord Davey and Terry Drummond, Founder of Good&Ready joined Steve Darling from Proactive to announce an exciting new video campaign focused on the daily struggles of those living with chronic pain. This marks Delivra’s first video campaign in several years, and it aims to deliver a fresh, humorous approach to a serious issue often overlooked in traditional pain relief ads.

The campaign features a series of three videos in 30, 15, and 6-second formats, crafted to connect with audiences by illustrating chronic pain as an “incessant background noise”—an analogy derived from in-depth consumer research by Delivra. The insights reveal that for many, chronic pain is like an unending, irritating soundtrack that can’t be silenced. To convey this experience, LivRelief partnered with the creative team at Good&Ready, co-led by Creative Director Terry Drummond, to develop a campaign that departs from conventional pain relief ads with a lighthearted twist.

“Our goal was to create a campaign for a pain relief cream that was a relief from the usual pain relief campaigns,” said Drummond. By using humor and relatability, the campaign hopes to resonate deeply with those affected by chronic pain, offering not only visibility to their experiences but also a sense of camaraderie and hope through LivRelief’s solutions

#proactiveinveestors #delivrahealthbrandsinc #tsxv #dhb #otcqb #dhbuf #DreamWater #GlobalExpansion #UAE #MiddleEastMarket #SleepAid #HealthAndWellness #PharmacyProducts #RegulatoryCompliance #DubaiWarehouse #ProductLaunch #MarketGrowth #InternationalBusiness #HealthSupplements #LabelTranslation

#invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews

North Bay Resources CEO Jared Lazerson joined Steve Darling from Proactive to reveal promising assay results from the company’s Murex Copper Project in British Columbia. These findings, based on geochemical sampling and geological mapping conducted during the Summer 2024 exploration season, showcased some of the highest-grade copper samples obtained from the property to date.

Lazerson detailed that sampling efforts focused on an area of complex fracture patterns around Mill Creek, particularly near the D and E zones. The D Zone, historically the most productive copper-bearing zone on the property, demonstrates a distinctive strike that extends continuously for approximately half a mile. This area shows signs of structural uplift, which could contribute to its rich copper concentrations.

The Murex Project is considered a transitional deposit, containing both copper and gold across various geological types, including breccia formations and copper-gold-bearing veins. Past drilling at the site has revealed both high-grade vein-type copper deposits, with copper concentrations reaching up to 9%, and large-scale, lower-grade mineralized sections, with continuous mineralization extending up to 390 feet. North Bay Resources is optimistic about the potential for significant copper-gold yields as exploration continues.

#proactiveinvestors #northbayresourcesinc #otc #nbri #PlatinumConcentrate #NorthBayResources #MiningNews #CaliforniaGold #JaredLazerson #GoldRush #ProactiveInvestors #PreciousMetals #MiningUpdates ---#invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews #invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews

Futura Medical Plc Head of R&D Ken James joined Steve Darling from Proactive to share the company’s latest developments in sexual health solutions. Futura’s flagship product, Eroxon, is a topical gel for erectile dysfunction (ED) that offers a rapid onset in under 10 minutes, setting it apart from traditional oral medications. “Eroxon has a very, very good side effect profile,” noted James, highlighting its suitability as an over-the-counter option for ED.

In response to consumer demand, Futura is developing an enhanced version called Eroxon Intense, catering to users seeking a stronger effect. This approach aligns with common consumer healthcare strategies, such as variations in pain relief formulations, allowing the company to meet diverse customer needs.

In addition to Eroxon, Futura is working on an innovative product targeting female sexual dysfunction—a pressing yet often overlooked need, especially post-menopause, affecting up to 50% of women according to research. This female-focused product is showing promising early study results, and Futura plans to advance to broader trials and engage with the U.S. FDA for over-the-counter approval.

With ongoing global partnerships and active engagement with regulatory authorities, Futura aims to establish a significant presence in both the male and female sexual health markets. These advancements are backed by extensive research and a solid financial foundation, positioning Futura as a leader in addressing critical gaps in sexual health solutions.

#proactiveinvestors #futuramedicalplc #aim #fum #ed #erectiledysfuntion #sexualhealth #femalesexualdysfunction #WomensHealth #FDAApproval #Pharmaceuticals #HealthcareInnovation #OTCProducts #ProactiveInvestors

#invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews

Proactive’s Tylah Tully breaks down ‘Just the Facts’ of the latest news from Titan Minerals Ltd (ASX:TTM, OTC:TTTNF).

The company has launched a diamond drilling campaign at the Dynasty Gold Project in southern Ecuador, focused on resource expansion and exploration of new zones. This campaign includes up to 10,000 metres of drilling aimed at upgrading inferred resources to the indicated category.

A recent trench result at the Iguana South prospect revealed high-grade intercepts, including 3 metres at 21.4 g/t gold and 14.1 g/t silver, which will be further examined in this drilling phase.

Titan’s exploration has confirmed a mineralised area of 9 x 2 kilometres within Dynasty, expanding the project’s potential.

New exploration targets have been identified using soil geochemistry and trenching, with ongoing drilling uncovering previously unmapped veins.

Concurrently, Titan is preparing a 10,000-metre drilling program at the nearby Linderos Copper Project.

This program will be funded by Hanrine, a Hancock Prospecting subsidiary, which can earn an 80% stake by investing up to USD $120 million.

The company aims to provide regular updates from the drilling and trenching activities over the coming months, with an expanded resource update anticipated by mid-2025.

#ProactiveInvestors #TitanMinerals #ASX #JusttheFacts #DynastyGoldProject #GoldExploration #CopperExploration #DrillingCampaign #MineralExpansion #SouthernEcuador #ResourceUpgrade #HighGradeResults #IguanaSouth #CerroVerde #LinderosProject #Hanrine #HancockProspecting #MiningUpdate #ASX #ResourceDevelopment #MineralExploration #Geochemistry #MiningNews

Proactive’s Tylah Tully breaks down ‘Just the Facts’ of the latest news from Eclipse Metals Ltd (ASX:EPM).

The company is advancing uranium exploration across extensive tenements in the Northern Territory, focusing on the Ngalia Basin and the Alligator Rivers Uranium Field.

In Ngalia Basin, the company holds exploration licences with drill-ready targets across a 15-kilometre paleochannel.

Recent gravity surveys and historical data suggest significant uranium potential, especially within the Afghan Swan and Y-series prospects, with past drilling indicating uranium oxide grades reaching 5.8%.

Eclipse’s total exploration area covers more than 7,500 square kilometres. Additional licence applications in the region have revealed uranium-vanadium-strontium mineralisation, supporting the project’s strategic value.

The company’s holdings also extend into the prolific Alligator Rivers Uranium Field, which includes the Devil’s Elbow prospect in West Arnhem Land.

Historical drilling at Devil’s Elbow has demonstrated high-grade uranium and gold, with 17 drill targets identified to enhance Eclipse’s exploration portfolio.

#ProactiveInvestors #EclipseMetals #ASX #JusttheFacts #UraniumExploration #NgaliaBasin #AlligatorRivers #GreenEnergy #CriticalMinerals #MiningAustralia #ExplorationTargets #HighGradeUranium #DrillReady #MineralResources #SustainableMining #NorthernTerritory #DevilsElbow #ESG #Palladium #Vanadium #GoldExploration #ResourceDelineation #U308